|
O.A. Polyakova, Yu.M. Tkachenko, O.D. Ostroumova
Relationship between non-alcoholic fatty liver disease and cardiovascular disease: focus on the use of ursodeoxycholic acid
|
№1-2 / 2023
|
|
Yu.P. Uspensky (1, 2), Yu.A. Fominykh (1, 2), A.A. Gnutov (1), V.N. Filippova (1)
Duodenogastroesophageal reflux and biliary pathology
|
№2 / 2021
|
|
E.Ya. Selezneva
Correction of functional biliary disorder – the real prevention of cholelithiasis
|
№2 / 2019
|
|
Yu.P. Uspensky (1, 2), N.V. Baryshnikova (2, 3), Y.A.Fominykh (2)
EXPERIENCE OF THE USE A SHORT COURSE OF URSODEOXYCHOLIC ACID IN PATIENTS WITH CHOLESTASIS PHENOMENA
|
№s3 / 2018
|
|
Yu.S. Gulenchenko (1), E.V. Partsvania-Vinogradova (2, 3), D.T. Dicheva (3), D.N. Andreev (3)
POTENTIALS FOR THE USE OF URSODEOXYCHOLIC ACID IN THE THERAPY OF INTRAHEPATIC CHOLESTASIS OF PREGNANCY
|
№15 / 2016
|
|
Yu.B. Uspenskaya
MODERN POSSIBILITIES OF PREVENTION AND TREATMENT OF CHOLELITHIASIS DURING PREGNANCY
|
№12 / 2016
|
|
V.V. Tsukanov (1), E.V. Kasparov (1), A.V. Vasyutin (2), E.V. Onuchina (2), Yu.L. Tonkikh (1), N.N. Butorin (3)
PREVALENCE AND PRINCIPLES OF MANAGEMENT OF PATIENTS WITH BARRETT'S ESOPHAGUS
|
№2 / 2016
|
|
O.B. Molochkova (1), T.V. Cherednichenko (1), O.B. Kovalev (1), G.V. Petrova (2)
ACUTE HEPATITIS A WITH CHOLESTASIS: DURING AND THERAPY
|
№11 / 2015
|
|
V.V. Cukanov (1), E.V. Onuchina (2), E.V. Kasparov (1), A.V. Vasjutin (1), Ju.L. Tonkih (1)
CLINICAL EXPERIENCE WITH LONG-TERM TREATMENT OF PATIENTS WITH BARRETT'S OESOPHAGUS
|
№2 / 2015
|
|
Yu.E. Poteshkin, V.S. Pronin, E.Yu. Kotlyarevskaya, E.V. Pronin, M.E. Morozova
ROLE OF URSODEOXYCHOLIC ACID IN THE PREVENTION OF CHOLELITHIASIS DURING TREATMENT OF ACROMEGALY USING SOMATOSTATIN ANALOGUES
|
№10 / 2013
|
|
D.I. Trukhan, L.V.Tarasova
CORRECTION OF EXOCRINE PANCREATIC INSUFFICIENCY IN CHRONIC BILIARY PANCREATITIS
|
№6 / 2013
|
|
Yu.V. Vasilyev
PRIMARY SCLEROSING CHOLANGITIS
|
№6 / 2013
|
Русский
